Molecular Partners AG (XSWX:MOLN) Ending Cash Position : CHF67.31 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Molecular Partners AG Ending Cash Position?

Molecular Partners AG's Ending Cash Position for the quarter that ended in Dec. 2023 was CHF67.31 Mil.

Molecular Partners AG's quarterly Ending Cash Position increased from Jun. 2023 (CHF63.24 Mil) to Sep. 2023 (CHF68.40 Mil) but then declined from Sep. 2023 (CHF68.40 Mil) to Dec. 2023 (CHF67.31 Mil).

Molecular Partners AG's annual Ending Cash Position increased from Dec. 2021 (CHF71.81 Mil) to Dec. 2022 (CHF87.95 Mil) but then declined from Dec. 2022 (CHF87.95 Mil) to Dec. 2023 (CHF67.31 Mil).

Molecular Partners AG Ending Cash Position Historical Data

The historical data trend for Molecular Partners AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Ending Cash Position Chart

Molecular Partners AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

75.71

133.72

71.81

87.95

67.31

Molecular Partners AG Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															87.95	73.93	63.24	68.40	67.31

Molecular Partners AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Molecular Partners AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	87.946	+	-20.637
	=	67.31

Molecular Partners AG's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	68.399	+	-1.09
	=	67.31

Molecular Partners AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Molecular Partners AG (XSWX:MOLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (XSWX:MOLN) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MOLN:USA MLLCF:USA MOLNz:UK 6ML0:Germany

Address

Wagistrasse 14, Schlieren, Zurich, CHE, 8952

Website

https://www.molecularpartners.com

Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.